Most Recent
International retail giant Gap has successfully opposed the registration of 'clothing the gap' as trade mark by an Aboriginal-owned social enterprise company which campaigns to improve the lives of Aboriginal people.
Litigation funder Omni Bridgeway has thrown its weight behind a David-versus-Goliath legal challenge by an inventor who accuses Coca-Cola of infringing a patent for a drink container and lid used in popular brands such as Mount Franklin water and Powerade sports drink.
The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured an image of the opera house sails together with the Great Wall of China.
A judge hearing Pfizer's application for preliminary discovery against Sandoz over its possible launch of an Enbrel biosimilar has found that such an application must be based on a current belief that the applicant could be entitled to relief.
A judge has enjoined Merck Sharpe and Dohme from launching its 15-valent pneumococcal conjugate vaccine after finding it would infringe claims of a Wyeth patent for its Prevnar 13 vaccine, despite MSD's argument that barring it from launching the vaccine would be contrary to the public interest.
Coca-Cola Amatil is facing a lawsuit for allegedly infringing an Australian company's patent for a drink container allegedly used in popular products like Mount Franklin water and Powerade sports drink.
An Australian concrete product maker has settled a lawsuit brought by US industrial equipment manufacturer Illinois Tool Works over its patents for precast concrete products.
Advanta Seeds has been denied more time to pay renewal fees for its patent for a hybrid plant cell after correspondence from its lawyers about the renewal was sent to employees that had left the company and the patent renewal fell through the cracks during a 2016 systems upgrade.
A judge has dismissed Pfizer's bid for preliminary discovery to pursue a possible patent infringement case against drug maker Sandoz over a generic version of its blockbuster rheumatoid arthritis biologic Enbrel.
The High Court won't wade into Kraft-Heinz's intellectual property dispute with Bega after the US food giant came up short twice its battle over the right to use its peanut butter trade dress in Australia.